The Chemical Bases of Behavior: Neurotransmitters and Neuropharmacology - PowerPoint PPT Presentation

1 / 95
About This Presentation
Title:

The Chemical Bases of Behavior: Neurotransmitters and Neuropharmacology

Description:

The Chemical Bases of Behavior: Neurotransmitters and Neuropharmacology 4 The Chemical Bases of Behavior: Neurotransmitters and Neuropharmacology Many Chemical ... – PowerPoint PPT presentation

Number of Views:503
Avg rating:3.0/5.0
Slides: 96
Provided by: nccubiops
Category:

less

Transcript and Presenter's Notes

Title: The Chemical Bases of Behavior: Neurotransmitters and Neuropharmacology


1
The Chemical Bases of Behavior Neurotransmitters
and Neuropharmacology
2
4 The Chemical Bases of Behavior
Neurotransmitters and Neuropharmacology
  • Many Chemical Neurotransmitters Have Been
    Identified
  • Neurotransmitter Systems Form a Complex Array in
    the Brain
  • Research on Drugs Ranges from Molecular Processes
    to Effects on Behavior (a focus by
    psychopharmacology)

3
4 The Chemical Bases of Behavior
Neurotransmitters and Neuropharmacology
  • Drugs Affect Each Stage of Neural Conduction and
    Synaptic Transmission (synapse pharmacology or
    neuropharmacology)
  • Drugs That Affect the Brain Can Be Divided into
    Functional Classes
  • Drug Abuse is Pervasive

4
4 Many Chemical Neurotransmitters Have Been
Identified
  • Neurochemistry focuses on the basic chemical
    composition and processes of the nervous system.
  • Neuropharmacology is the study of compounds that
    selectively affect the nervous system.

5
4 Many Chemical Neurotransmitters Have Been
Identified
  • Criteria for neurotransmitters chemicals
    released onto target cells
  • Substance exists in presynaptic axon terminals
    (precursor)
  • synthesized in presynaptic cells
  • released when action potentials reach axon
    terminals
  • Receptors for the substance exist on postsynaptic
    membrane
  • When applied, substance produces changes in
    postsynaptic potentials
  • Blocking substance release prevents changes in
    postsynaptic cell
  • Deactivation by enzyme or re-uptake transporter

6
4 Many Chemical Neurotransmitters Have Been
Identified
  • Types of neurotransmitters
  • Amine neurotransmitters acetylcholine,
    dopamine, serotonin
  • Amino acid neurotransmitters GABA, glutamate
  • Peptide neurotransmitters
  • Gas neurotransmitters

7
4 Many Chemical Neurotransmitters Have Been
Identified
  • Neurotransmitters affect targets by acting on
    receptors protein molecules in the postsynaptic
    membrane
  • Ionotropic receptors are fast open an ion
    channel when the transmitter molecule binds
  • Metabotropic receptors are slow when activated
    alter chemical reactions in the cell, such as a G
    protein system, to open an ion channel

8
4 Many Chemical Neurotransmitters Have Been
Identified
  • Receptor subtypes the same neurotransmitter may
    bind to a variety of subtypes, which trigger
    different responses
  • DA1, DA2, DA3, DA4, DA5

9

Figure 4.1 The Versatility of Neurotransmitters
10
4 Many Chemical Neurotransmitters Have Been
Identified
  • A ligand is a substance that binds to a receptor
    and has one of three effects
  • An agonist initiates the normal effects of the
    receptor
  • An antagonist blocks the receptor from being
    activated by other ligands
  • An inverse agonist initiates an effect that is
    the opposite of the normal function

11
4 Many Chemical Neurotransmitters Have Been
Identified
  • Endogenous occurs naturally within the body
  • Endogenous ligands substances that the brain
    produces (neurotransmitter)
  • Exogenous introduced from outside the body
  • in opiates, endorphin/enkephalin vs. morphine

12
4 Neurotransmitter Systems Form a Complex Array
in the Brain
  • Co-localization or co-release occurs when
    nerve cells contain more than one type of
    neurotransmitter.
  • Acetylcholine (ACh) was mapped by the enzymes
    involved in its synthesis.
  • Cholinergic nerve cell bodies and projections
    contain ACh.

13
Figure 4.2 Cholinergic Pathways in the Brain
14
4 Neurotransmitter Systems Form a Complex Array
in the Brain
  • Two types of ACh receptors
  • Nicotinic most are ionotropic and excitatory
  • Example muscles use nicotinic ACh receptors
    paralysis can be induced with an antagonist, such
    as curare
  • Muscarinic are metabotropic and can be
    excitatory or inhibitory
  • Muscarinic ACh receptors can be blocked by
    atropine or scopolamine to produces changes in
    cognition.

15
4 Neurotransmitter Systems Form a Complex Array
in the Brain
  • Two main classes of monoamine neurotransmitters
  • Catecholamines dopamine (DA), epinephrine,
    norepinephrine (NE)
  • Indoleamines serotonin (5-HT), melatonin

16
4 Neurotransmitter Systems Form a Complex Array
in the Brain
  • Dopamine (DA) is found in neurons in
  • (1) The mesostriatal pathway originates in the
    midbrain, specifically the substantia nigra, and
    innervates the striatum
  • - This pathway is important in motor control and
    neuronal loss is a cause of Parkinsons disease.
  • (2) The mesolimbocortical DA pathway originates
    in the midbrain in the ventral tegmental area
    (VTA) and projects to the limbic system and
    cortex.
  • - This pathway is involved in reward,
    reinforcement and learning abnormalities are
    associated with schizophrenia.

17
Figure 4.3 Dopaminergic Pathways in the Brain
18
4 Neurotransmitter Systems Form a Complex Array
in the Brain
  • Norepinephrine (NE) is released in three
    brainstem regions
  • Locus coeruleus (pons)
  • Lateral tegmental system (midbrain)
  • Dorsal medullary group
  • NE is also known as noradrenaline cells
    producing it are noradrenergic

19
4 Neurotransmitter Systems Form a Complex Array
in the Brain
  • Noradrenergic fibers from the locus coeruleus
    project broadly.
  • The CNS has four subtypes of NE receptors all
    metabotropic.
  • The NE systems modulate processes including mood,
    arousal, and sexual behavior.

20

Figure 4.4 Noradrenergic Pathways in the Brain
21
4 Neurotransmitter Systems Form a Complex Array
in the Brain
  • Serotonin (5HT) cell bodies are mainly found in
    the raphe nuclei. Serotonergic fibers projecting
    from the dorsal raphe exert widespread influence.
  • Serotonin is implicated in sleep, mood, sexual
    behavior, and anxiety.
  • Antidepressants such as Prozac increase 5HT
    activity, with effects depending on which
    receptor subtype is affected.

22

Figure 4.5 Serotonergic Pathways in the Brain
23
4 Neurotransmitter Systems Form a Complex Array
in the Brain
  • Amino acid transmitters
  • Glutamate and aspartate
  • excitatory (to generate EPSP)
  • Glutamatergic transmission uses AMPA, kainate,
    and NMDA receptors.

24
4 Neurotransmitter Systems Form a Complex Array
in the Brain
  • Glutamate also acts on mGluRs slower
    metabotropic receptors
  • Excitotoxicity neural injury such as stroke may
    cause excess release of glutamate, which is toxic
    to neurons
  • Astrocytes are involved in the uptake of
    glutamate from the synapses.

25
4 Neurotransmitter Systems Form a Complex Array
in the Brain
  • Other amino acid transmitters
  • Gamma-aminobutyric acid (GABA) and glycine
    inhibitory

26
4 Neurotransmitter Systems Form a Complex Array
in the Brain
  • GABA receptors are in 3 classes
  • GABAA - ionotropic, producing fast, inhibitory
    effects
  • GABAB - metabotropic, slow inhibitory effects
    through neurogliaform interneurons
  • GABAC - ionotropic with a chloride channel
  • GABA agonists, like Valium (a benzodiazepine),
    are potent tranquilizers to facilitate sleep
    anti-anxiety

27
4 Neurotransmitter Systems Form a Complex Array
in the Brain
  • Peptides act as neurotransmitters at some
    synapses, or as hormones
  • Opioid peptides mimic opiate drugs such as
    morphine
  • Peptides in gut (e.g. cholecystokinin, CCK)
  • Peptides in spinal cord or brain (e.g. neural
    growth factor NGF)
  • Pituitary hormones (e.g. oxytocin, ACTH)

28
4 Neurotransmitter Systems Form a Complex Array
in the Brain
  • The gas, nitric oxide (NO), differs from other
    neurotransmitters
  • produced in locations other than axon terminals
    mainly in dendrites, and diffuses as soon as it
    is produced, rather than released
  • diffused into the target cell and to activate
    cyclic GMP
  • to serve as a retrograde transmitter by diffusing
    back into the presynaptic neuron

29
4 Research on Drugs Ranges from Molecular
Processes to Effects on Behavior
  • Many drugs are ligands that act upon specific
    receptor molecules.
  • Drugs may target one or a few receptor subtypes.
    (selectivity or specificity)
  • Because receptor subtypes have different
    localizations and functions, drug actions can
    have widely varying effects. (?????,?????)

30
4 Research on Drugs Ranges from Molecular
Processes to Effects on Behavior
  • The binding affinity (or affinity) is the degree
    of chemical attraction between a ligand and a
    receptor.
  • The efficacy (or intrinsic activity) is the
    ability of a bound ligand to activate the
    receptor.

31
Figure 4.6 Using Binding Affinity to Compare
Drug Effectiveness
32
4 Research on Drugs Ranges from Molecular
Processes to Effects on Behavior
  • Agonists to activate the receptor and its
    function.
  • Partial agonists produce a medium response
    regardless of dose.
  • Competitive ligands are drugs that bind to the
    same receptor site as the neurotransmitter.
  • A noncompetitive ligand binds instead to a
    modulatory site on the receptor.
  • competitive vs. non-competitive antagonist (next
    slide)

33
Figure 4.7 The Agonistic and Antagonistic
Actions of Drugs
34
4 Research on Drugs Ranges from Molecular
Processes to Effects on Behavior
  • A dose-response curve (DRC) is a graph of the
    relationship between drug doses and the effects.
  • The DRC is a tool to understand pharmacodynamics
    the functional relationship between drugs and
    their targets.

35
4 Research on Drugs Ranges from Molecular
Processes to Effects on Behavior
  • A DRC has a characteristic slanted S shape
  • No response at low doses
  • Maximal response adding more drug cannot
    produce any further response
  • At very high doses receptors are saturated
  • ED50 (effective dose 50) gives a half-maximal
    response

36
Box 4.1 (A) Mind the Curves
37
4 Research on Drugs Ranges from Molecular
Processes to Effects on Behavior
  • Relative potency of two drugs can be compared by
    their ED50 values.
  • A drug that has comparable effects at lower doses
    is more potent.
  • Chemically related drugs congeners are
    compared this way.

38
Box 4.1 (B) Mind the Curves
39
4 Research on Drugs Ranges from Molecular
Processes to Effects on Behavior
  • Drug efficacy is based on maximal responses, not
    doses.
  • A partial agonist or antagonist has only moderate
    efficacy.

40
4 Research on Drugs Ranges from Molecular
Processes to Effects on Behavior
  • Secondary Binding
  • A nonmonotonic DRC is the result of very high
    doses after a point the effects begin to
    reverse or fluctuate
  • The drug has saturated all of its high affinity
    sites and is beginning to act elsewhere on lower
    affinity sites

41
4 Research on Drugs Ranges from Molecular
Processes to Effects on Behavior
  • The therapeutic index of a drug measures its
    safety the separation between useful and toxic
    doses
  • Compares ED50 with LD50 (lethal doses) or TD50
    (toxic doses)

42
Box 4.1 (E) Mind the Curves
43
4 Research on Drugs Ranges from Molecular
Processes to Effects on Behavior
  • Drug tolerance can develop successive (in
    chronic) treatments have decreasing effects
  • Metabolic tolerance organ systems become more
    effective at eliminating the drug
  • Functional tolerance target tissue may show
    altered sensitivity to the drug

44
4 Research on Drugs Ranges from Molecular
Processes to Effects on Behavior
  • Changes in numbers of receptors can alter
    sensitivity in the direction opposite to the
    drugs effects
  • Neurons down-regulate in response to an agonist
    drug fewer receptors available
  • They up-regulate in response to an antagonist.

45
4 Research on Drugs Ranges from Molecular
Processes to Effects on Behavior
  • Cross-tolerance is tolerance to a whole class of
    chemically similar drugs.
  • Withdrawal symptoms may be caused by drug
    tolerance and generally appeared in an abrupt
    stop for drug taking.
  • Sensitization occurs when drug effects become
    stronger with repeated treatment.

46
4 Research on Drugs Ranges from Molecular
Processes to Effects on Behavior
  • The amount of drug that is bioavailable free to
    act on the target varies with route of
    ingestion.
  • Duration of a drugs effect is determined by how
    it is metabolized.
  • Biotransformation produces active metabolites
    that may produce side effects.

47
4 Research on Drugs Ranges from Molecular
Processes to Effects on Behavior
  • Pharmacokinetics refer to factors that affect the
    movement of a drug through the body.
  • The blood-brain barrier tight junctions within
    the CNS that prevent the movement of large
    molecules can limit drug availability.

48
4 Drugs Affect Each Stage of Neural Conduction
and Synaptic Transmission
  • Presynaptic events are affected by drugs
  • Inhibit axonal transport
  • Prevent release of neurotransmitter
  • Example botulism toxin prevents the release of
    ACh onto muscles

49
4 Drugs Affect Each Stage of Neural Conduction
and Synaptic Transmission
  • Neuromodulators affect either transmitter release
    or receptor response.
  • Caffeine is an exogenous neuromodulator that
    blocks the effect of adenosine, an endogenous
    neuromodulator that normally inhibits
    catecholamine release.

50
4 Drugs Affect Each Stage of Neural Conduction
and Synaptic Transmission
  • Caffeine thus stimulates catecholamine release,
    causing arousal.
  • Adenosine is normally released along with the
    catecholamines and acts on autoreceptors
    receptors on the same terminal that released it.

51

Figure 4.8 Steps in Synaptic Transmission That
Are Affected by Drugs (Part 1)
52
4 Drugs Affect Each Stage of Neural Conduction
and Synaptic Transmission
  • Postsynaptic receptors can be blocked or
    activated by drugs.
  • Prolonged transmitter receptor activity can
    alter behavior
  • Cholinesterase inhibitors inhibit the breakdown
    of ACh at the synapse by the enzyme AChE, causing
    prolonged muscle contraction

53

Figure 4.8 Steps in Synaptic Transmission That
Are Affected by Drugs (Part 2)
54
4 Drugs That Affect the Brain Can Be Divided
into Functional Classes
  • Antipsychotic (neuroleptic) drugsa class of
    drugs to treat schizophrenia
  • Typical neuroleptics are selective dopamine D2
    anagonists.
  • Atypical neuroleptics block serotonin receptors
    and may reduce negative symptoms of schizophrenia.

55
4 Drugs That Affect the Brain Can Be Divided
into Functional Classes
  • 2 types of Antidepressants treat depression.
    (1/2)
  • Monoamine oxidase inhibitors (MAOIs) prevent the
    breakdown of monoamines at the synapses.
  • Accumulation of monoamines and prolonging their
    activity is a major feature of antidepressants.

56
4 Drugs That Affect the Brain Can Be Divided
into Functional Classes
  • (2/2) Tricyclics antidepressant drugs increase
    norepinephrine and serotonin at the synapses by
    blocking their reuptake into presynaptic axon
    terminals.
  • Selective serotonin reuptake inhibitors (SSRIs)
    like Prozac or Zoloft allow serotonin to
    accumulate in the synapses, with fewer side
    effects than tricyclics.

57
4 Drugs That Affect the Brain Can Be Divided
into Functional Classes
  • Anxiolytics, or tranquilizers, are depressants
    drugs that reduce nervous system activity.
  • Benzodiazepine agonists act on GABAA receptors
    and enhance the inhibitory effects of GABA.

58
4 Drugs That Affect the Brain Can Be Divided
into Functional Classes
  • GABA receptors have several binding sites, some
    that enhance and some that inhibit GABAs
    effects.
  • Benzodiazepines bind at an orphan receptor no
    endogenous ligand has been found.
  • Allopregnanolone, a steroid related to
    progesterone, as released under stress, is a
    candidate.
  • Other neurosteroids (steroids produced in the
    brain) may act on GABAA sites.

59
Figure 4.9 The GABAA Receptor Has Many Different
Binding Sites
60
4 Drugs That Affect the Brain Can Be Divided
into Functional Classes
  • Alcohols effects are biphasic an initial
    stimulant phase followed by a depressant phase.
  • Alcohol activates GABAA receptors and increases
    inhibitory effects.
  • This contributes to social disinhibition and loss
    of motor coordination.

61
4 Drugs That Affect the Brain Can Be Divided
into Functional Classes
  • Alcohol also stimulates dopamine pathways,
    causing euphoric effects.
  • Alcohol abuse damages nerve cells especially in
    the frontal lobe, cerebellum hippocampus, yet
    some damage is reversible.
  • Korsakoffs syndrome with thiamine deficiency
  • Fetal alcohol syndrome is the result of pregnant
    women abusing alcohol, with permanent damage to
    the fetus.

62

Figure 4.10 The Effects of Alcohol on the Brain
63
4 Drugs That Affect the Brain Can Be Divided
into Functional Classes
  • Alcoholism has a genetic component
  • 20-50 of sons and 8-10 of daughters of
    alcoholics will eventually develop the disease
  • Periodic overconsumption, or bingeing, may cause
    brain damage and reduces neurogenesis. (????,????)

64
4 Drugs That Affect the Brain Can Be Divided
into Functional Classes
  • Opium contains morphine, an effective analgesic,
    or painkiller.
  • Morphine and heroin are both highly addictive.
  • These opiates bind to opioid receptors in the
    brain, especially in the locus coeruleus and the
    periaqueductal gray.

65
4 Drugs That Affect the Brain Can Be Divided
into Functional Classes
  • Endogenous opiates- peptides that bind to opioid
    receptors (µ, ?, d) and relieve pain- also are
    addictive
  • Enkephalins
  • Endorphins
  • Dynorphins

66
4 Drugs That Affect the Brain Can Be Divided
into Functional Classes
  • Marijuana is derived from Cannabis sativa its
    active ingredient is
    ?9-tetrahydrocannabinol (THC)
  • Effects vary - include relaxation, mood
    alteration, stimulation, hallucination and
    paranoia
  • Sustained use can cause addiction.

67
Figure 4.13 An Indoor Marijuana Farm
68
4 Drugs That Affect the Brain Can Be Divided
into Functional Classes
  • The brain contains orphan cannabinoid receptors
    to mediate the effects of THC and other
    compounds.
  • Endocannabinoids (eg. anandamide)
  • - homologs of marijuana produced in the brain
  • - act as retrograde messengers and may influence
    the release of neurotransmitter from the
    presynaptic neuron

69
4 Drugs That Affect the Brain Can Be Divided
into Functional Classes
  • Anandamide is an endocannabinoid with many
    effects
  • Altered memory formation
  • Appetite stimulation
  • Reduced pain sensitivity
  • Protection from excitotoxic brain damage
  • Other endocannabinoids 2-arachidonyl-glycerol
    (2-AG), oleamide

70
4 Drugs That Affect the Brain Can Be Divided
into Functional Classes
  • Stimulants increase nervous system activity.
  • Nicotine from tobacco
  • to increase heart rate, blood pressure,
    hydrochloric acid secretion, and bowel activity
  • to activate nicotinic ACh receptors in the
    ventral tegmental area (VTA) of mesolimbic DA
    pathway
  • functionally related to drug addiction
  • excitatory action of nicotinic receptors in CNS
    as to that on the neuromuscular junction in PNS

71
4 Drugs That Affect the Brain Can Be Divided
into Functional Classes
  • Leaves from the coca shrub alleviate hunger,
    promote endurance and enhance sense of
    well-being.
  • Cocaine, the purified extract
  • used as an local anesthetic
  • increases of catecholamine stimulation
  • to enhance the release to block the re-uptake
  • highly addictive

72
4 Drugs That Affect the Brain Can Be Divided
into Functional Classes
  • Crack cocaine is smoked and enters the brain more
    rapidly.
  • Cocaine blocks monoamine transporters, especially
    dopamine slows reuptake of neurotransmitters,
    enhancing their effects
  • Dual dependence is addiction to the effects of
    the interaction of two drugs, frequently seen in
    cocaine abuser

73
Figure 4.15 Cocaine-Binding Sites in the Monkey
Brain
74
4 Drugs That Affect the Brain Can Be Divided
into Functional Classes
  • Amphetamine and methamphetamine are synthetic
    stimulants that resembles catecholamines in
    structure.
  • They cause the release of neurotransmitters even
    in the absence of action potentials.

75
4 Drugs That Affect the Brain Can Be Divided
into Functional Classes
  • Short-term effects of amphetamine include
    alertness, euphoria and stamina (the enhanced
    power in physical mental).
  • Long-term use leads to sleeplessness, weight
    loss, and schizophrenic symptoms.
  • Cocaine- and amphetamine-regulated transcript
    (CART) - a peptide produced in the brain which
    may be involved in the pleasure sensations from
    the drugs

76
4 Drugs That Affect the Brain Can Be Divided
into Functional Classes
  • Hallucinogens alter sensory perception and
    produce peculiar experiences.
  • LSD (acid), mescaline (peyote), and psilocybin
    (magic mushrooms) have mainly visual effects.

77
4 Drugs That Affect the Brain Can Be Divided
into Functional Classes
  • Hallucinogens have diverse neural actions,
    including on the noradrenergic, serotonergic, and
    ACh systems.
  • LSD resembles serotonin in structure and it acts
    as an agonist on 5-HT receptors, including in the
    visual cortex.

Albert Hofmann the father of LSD
78
4 Drugs That Affect the Brain Can Be Divided
into Functional Classes
  • Phencyclidine (PCP) or angel dust, is a
    dissociative drug it produces feelings of
    depersonalization and detachment from reality
  • PCP as a NMDA receptor antagonist, indirectly
    stimulating dopamine release
  • Its many side effects include combativeness and
    catatonia.
  • PCP has been proposed as a chemical model for
    schizophrenia.

79
4 Drugs That Affect the Brain Can Be Divided
into Functional Classes
  • Ketamine (Special K) is a less potent NMDA
    antagonist that works in the prefrontal cortex (?
    metabotropic act.)
  • Like PCP it can produce transient psychotic
    symptoms, at high doses.

80
4 Drugs That Affect the Brain Can Be Divided
into Functional Classes
  • MDMA (Ecstasy) is a hallucinogenic amphetamine
    derivative its major actions are increases in
    serotonin levels (on 5-HT2 R) and changes in
    dopamine and prolactin levels
  • Chronic ecstasy use produces persistent effects
    and damage to serotonin-producing neurons.

81

Figure 4.17 Long-Term Effects of a Single Dose
of Ecstasy on the Monkey Brain
82
4 Drug Abuse Is Pervasive
  • Substance-Related Disorders
  • Dependence (addiction) is the desire to
    self-administer a drug of abuse criteria
    include patterns of consumption, craving, time
    and energy, and impact on ones life
  • It is a more severe disorder than substance
    abuse, which is a pattern of use that does not
    fully meet the criteria for dependence.

83
4 Drug Abuse Is Pervasive
  • Models of drug abuse
  • The Moral Model blames the abuser for a lack of
    moral character or a lack of self-control
  • The Disease Model says the abuser requires
    medical treatment however, researchers have not
    been able to identify an abnormal condition in
    abusers

84
4 Drug Abuse Is Pervasive
  • Models of drug abuse
  • The Physical Dependence Model called the
    withdrawal avoidance model, says abusers use
    drugs to avoid withdrawal symptoms
  • The Positive Reward Model says drug use is a
    behavior controlled by positive rewards or
    incentive, with no disease

85

Figure 4.18 Experimental Setup for
Self-Administration of a Drug by an Animal
86
4 Drug Abuse Is Pervasive
  • Many addictive drugs cause dopamine release in
    the nucleus accumbens.
  • Some axons that terminate here originate in the
    ventral tegmental area (VTA) and are involved in
    the reward pathway.
  • The addictive power of drugs may come from
    stimulating this pathway.

87
Figure 4.19 A Neural Pathway Implicated in Drug
Abuse (Part 1)
88

Figure 4.19 A Neural Pathway Implicated in Drug
Abuse (Part 2)
89
4 Drug Abuse Is Pervasive
  • Factors in susceptibility to addiction
  • Biological sex, genetic predisposition
  • Personal characteristics aggressiveness,
    emotional control
  • Family situation family breakup, poor
    relationships, sibling drug users
  • Environmental factors peer pressure, social
    factors

90
4 Drug Abuse Is Pervasive
  • Environmental stimuli can become associated with
    the effects of drugs.
  • Cue-induced drug use is the increased likelihood
    of using a drug because factors are present that
    were also present when the drug was last used.

91
4 Drug Abuse Is Pervasive
  • Cravings that occur with environmental cues are
    mediated by the extracellular signal-regulated
    kinase (ERK) pathway.
  • Orexin, a peptide associated with hunger, may
    also contribute to craving.

92
4 Drug Abuse Is Pervasive
  • 6 Medications to treat drug abuse
  • Drugs for detoxification benzodiazepines and
    drugs to help ease withdrawal symptoms
  • Replacement treatment by agonists or analogs of
    the addictive drug these partially activate the
    same pathways, such as methadone or nicotine
    patches

93
4 Drug Abuse Is Pervasive
  • Antagonists to the addictive drug block effects
    of the abused drug but may produce withdrawal
    symptoms
  • Medications that alter drug metabolism like
    disulfiram (Antabuse), which makes drinking
    produce unpleasant side effects

94
4 Drug Abuse Is Pervasive
  • Reward-blocking medications (DA receptor
    antagonist) block positive reward effects of
    the abused drug but may produce anhedonia a
    lack of all pleasurable feelings
  • Anticraving medications reduce the appetite for
    the abused substance

95
4 Drug Abuse Is Pervasive
  • Vaccines may one day prompt the immune system to
    produce antibodies to remove substances from
    circulation before they reach the brain.
  • Viruses can help deliver antibodies across the
    blood-brain barrier and block a drugs effects.
Write a Comment
User Comments (0)
About PowerShow.com